CROT (Carnitine O-Octanoyltransferase) Is a Novel Contributing Factor in Vascular Calcification via Promoting Fatty Acid Metabolism and Mitochondrial Dysfunction.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 29 12 2020
medline: 2 6 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Vascular calcification is a critical pathology associated with increased cardiovascular event risk, but there are no Food and Drug Administration-approved anticalcific therapies. We hypothesized and validated that an unbiased screening approach would identify novel mediators of human vascular calcification. Approach and Results: We performed an unbiased quantitative proteomics and pathway network analysis that identified increased CROT (carnitine O-octanoyltransferase) in calcifying primary human coronary artery smooth muscle cells (SMCs). Additionally, human carotid artery atherosclerotic plaques contained increased immunoreactive CROT near calcified regions. CROT is a novel contributing factor in vascular calcification via promoting fatty acid metabolism and mitochondrial dysfunction, as such CROT inhibition has strong potential as an antifibrocalcific therapy.

Identifiants

pubmed: 33356393
doi: 10.1161/ATVBAHA.120.315007
pmc: PMC8105275
mid: NIHMS1654798
doi:

Substances chimiques

Fatty Acids 0
Proteome 0
Receptors, LDL 0
Carnitine Acyltransferases EC 2.3.1.-
carnitine octanoyltransferase EC 2.3.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

755-768

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL136431
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141917
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL147095
Pays : United States

Références

Proc Natl Acad Sci U S A. 2011 May 31;108(22):9232-7
pubmed: 21576456
Circulation. 2007 Jan 23;115(3):377-86
pubmed: 17224478
Atherosclerosis. 2011 Mar;215(1):43-51
pubmed: 21193197
Trends Endocrinol Metab. 2014 Sep;25(9):481-7
pubmed: 25034130
J Biol Chem. 2005 Jan 7;280(1):738-44
pubmed: 15492013
Circ Res. 2006 Mar 31;98(6):727-9
pubmed: 16514067
Kidney Int. 2004 Dec;66(6):2293-9
pubmed: 15569318
Exp Mol Pathol. 1985 Apr;42(2):139-62
pubmed: 3884359
J Vasc Surg. 2007 Jun;45 Suppl A:A25-32
pubmed: 17544021
Nat Rev Cardiol. 2019 May;16(5):261-274
pubmed: 30531869
Nature. 2014 Jun 5;510(7503):92-101
pubmed: 24899309
Heart. 2014 Apr;100(7):569-73
pubmed: 24352736
Nat Mater. 2016 Mar;15(3):335-43
pubmed: 26752654
Eur J Clin Nutr. 2020 Apr;74(4):651-656
pubmed: 31896827
Biochem Biophys Res Commun. 2011 Jun 17;409(4):699-704
pubmed: 21619872
JAMA. 2004 Jan 14;291(2):210-5
pubmed: 14722147
J Clin Invest. 2016 Apr 1;126(4):1323-36
pubmed: 26950419
Circ Genom Precis Med. 2020 Jun;13(3):e002710
pubmed: 32397743
Semin Immunopathol. 2019 Nov;41(6):757-766
pubmed: 31696250
Prostaglandins Leukot Essent Fatty Acids. 1998 Sep;59(3):221-7
pubmed: 9844996
Nutrients. 2017 Aug 10;9(8):
pubmed: 28796175
Int Rev Cell Mol Biol. 2011;288:43-99
pubmed: 21482410
Circulation. 2006 Oct 17;114(16):1761-91
pubmed: 17015792
Circulation. 2020 May 26;141(21):1670-1680
pubmed: 32223336
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):656-669
pubmed: 31852220
Sci Adv. 2020 Sep 16;6(38):
pubmed: 32938681
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Circ Res. 2013 Jun 21;113(1):72-7
pubmed: 23616621
Circ Res. 2017 Jul 21;121(3):220-233
pubmed: 28607103
Nat Rev Cardiol. 2019 Dec;16(12):727-744
pubmed: 31243391
PLoS One. 2017 Aug 3;12(8):e0181009
pubmed: 28771600
Mol Genet Metab. 2000 Sep-Oct;71(1-2):139-53
pubmed: 11001805
Front Cardiovasc Med. 2019 Apr 16;6:49
pubmed: 31041314
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):e214-e226
pubmed: 32493171
J Biol Chem. 1984 Nov 10;259(21):13089-95
pubmed: 6436243
Mol Metab. 2018 Sep;15:45-55
pubmed: 29858147
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10741-6
pubmed: 23733926
J Proteome Res. 2019 Feb 1;18(2):775-781
pubmed: 30370770
Biochem Biophys Res Commun. 1999 Sep 16;263(1):213-8
pubmed: 10486279

Auteurs

Takehito Okui (T)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Masaya Iwashita (M)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Maximillian A Rogers (MA)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Arda Halu (A)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Samantha K Atkins (SK)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Shiori Kuraoka (S)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Ilyes Abdelhamid (I)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Hideyuki Higashi (H)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Ashisha Ramsaroop (A)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Masanori Aikawa (M)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Center for Excellence in Vascular Biology, Cardiovascular Division (M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Sasha A Singh (SA)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Elena Aikawa (E)

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine (T.O., M.I., M.A.R., A.H., S.K.A., S.K., I.A., H.H., A.R., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Center for Excellence in Vascular Biology, Cardiovascular Division (M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Department of Human Pathology, Sechenov First Moscow State Medical University, Russia (E.A.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH